标题
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 10, Pages 2505
出版商
MDPI AG
发表日期
2019-05-21
DOI
10.3390/ijms20102505
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
- (2018) Sanhong Li et al. APOPTOSIS
- PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
- (2018) Xin Yao Qiu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma
- (2018) Yulin Sun et al. CANCER LETTERS
- Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel
- (2018) Ying Jin et al. CANCER LETTERS
- Inhibition of Rspo-Lgr4 facilitates checkpoint blockade therapy by switching macrophage polarization
- (2018) Binghe Tan et al. CANCER RESEARCH
- Erbin suppresses KSR1-mediated RAS/RAF signaling and tumorigenesis in colorectal cancer
- (2018) Payton D Stevens et al. CANCER RESEARCH
- Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance
- (2018) Lin Zhou et al. CANCER SCIENCE
- Oncogenic KRAS suppresses store-operated Ca 2+ entry and I CRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines
- (2018) Cristina Pierro et al. CELL CALCIUM
- Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer
- (2018) Xianmin Mu et al. CELL CYCLE
- FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
- (2018) Min Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated protein kinase signalling pathway in human colorectal can
- (2018) Nengyi Hou et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer
- (2018) Jiangyong Yu et al. CLINICAL CANCER RESEARCH
- Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
- (2018) Dipongkor Saha et al. CLINICAL CANCER RESEARCH
- Regulation of IL-1 signaling through control of focal adhesion assembly
- (2018) Qin Wang et al. FASEB JOURNAL
- NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer
- (2018) Xiaodi Jiang et al. GENE
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Immune suppression and reversal of the suppressive tumor microenvironment
- (2018) Kanako Shimizu et al. INTERNATIONAL IMMUNOLOGY
- Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy
- (2018) Xiao-Yan Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inhibition of interleukin 8/C‑X-C chemokine receptor�1,/2 signaling reduces malignant features in human pancreatic cancer cells
- (2018) Shengling Fu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway
- (2018) Wenjie Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer
- (2018) Imran Hussain et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
- (2018) Xiaoran Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mitochondrial fission promotes cell migration by Ca2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma
- (2018) Xiacheng Sun et al. LIVER INTERNATIONAL
- The Unfolded Protein Response: A Novel Therapeutic Target for Poor PrognosticBRAFMutant Colorectal Cancer
- (2018) Nicholas Forsythe et al. MOLECULAR CANCER THERAPEUTICS
- Notch Pathway Inhibition Using DAPT, a γ-secretase inhibitor (GSI), Enhances the Antitumor Effect of Cisplatin in Resistant Osteosarcoma
- (2018) Guo Dai et al. MOLECULAR CARCINOGENESIS
- Calotropin regulates the apoptosis of non‑small cell cancer by regulating the cytotoxic T‑lymphocyte associated antigen 4‑mediated TGF‑β/ERK signaling pathway
- (2018) Lu Tian et al. Molecular Medicine Reports
- Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
- (2018) Ioannis Zerdes et al. ONCOGENE
- Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
- (2018) Zunyue Zhang et al. ONCOGENE
- TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells
- (2018) Xiancheng Ma et al. ONCOLOGY REPORTS
- Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells
- (2018) Siriporn Keeratichamroen et al. ONCOLOGY REPORTS
- miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
- (2018) Danni Chen et al. Cell Death & Disease
- Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence
- (2018) Jie Dou et al. Oncotarget
- Cytoprotective mechanisms of DJ-1 against oxidative stress through modulating ERK1/2 and ASK1 signal transduction
- (2018) Stephanie E. Oh et al. Redox Biology
- Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
- (2018) Feifei Liu et al. Acta Pharmaceutica Sinica B
- Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo
- (2018) Zhiqiang Zhang et al. Acta Pharmaceutica Sinica B
- Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways
- (2018) Shun-Le Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway
- (2018) Ping Yang et al. CANCER LETTERS
- UBE2N promotes melanoma growth via MEK/FRA1/SOX10 signaling
- (2018) Anushka Dikshit et al. CANCER RESEARCH
- Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
- (2018) Haitao Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
- (2018) Dimakatso Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway
- (2018) L. J. Bugaj et al. SCIENCE
- HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
- (2018) Chih-Yang Huang et al. Cell Death & Disease
- SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling
- (2018) Yan Ma et al. Experimental and Therapeutic Medicine
- Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo
- (2018) Chang Li et al. Scientific Reports
- Krukovine Suppresses KRAS-Mutated Lung Cancer Cell Growth and Proliferation by Inhibiting the RAF-ERK Pathway and Inactivating AKT Pathway
- (2018) Huanling Lai et al. Frontiers in Pharmacology
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non–small cell lung cancer via persistent activation of ERK signalling
- (2017) Po-Lin Lin et al. EUROPEAN JOURNAL OF CANCER
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway
- (2017) Ratna Kumari et al. JOURNAL OF BIOSCIENCES
- Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas
- (2017) Sofia S. Pereira et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+ -mediated apoptosis pathways in MCF-7/ADR and K562/ADR
- (2017) Yaoting Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
- (2017) Cecilia S. Leung et al. JOURNAL OF CLINICAL INVESTIGATION
- Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma
- (2017) Hiroyuki Cho et al. Journal of Thoracic Oncology
- CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway
- (2017) Feng Tang et al. Molecular Medicine Reports
- Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
- (2017) Mengqi Yang et al. Molecular Oncology
- ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
- (2017) M R Yun et al. ONCOGENE
- Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
- (2017) Yan Li et al. ONCOLOGY REPORTS
- Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
- (2017) Weiwei Sheng et al. Cell Death & Disease
- Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
- (2017) Huijun Zeng et al. Cell Death & Disease
- IL‑8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells
- (2017) Linlin Jia et al. Oncology Letters
- Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
- (2017) Jennifer P. Newman et al. Nature Communications
- IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
- (2017) Kazuyoshi Takeda et al. Nature Communications
- Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue
- (2017) Eleonora Franzè et al. Oncotarget
- The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
- (2017) Emilie Laprevotte et al. Oncotarget
- SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells
- (2017) Zhuqing Liu et al. Oncotarget
- Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
- (2017) Chan-Young Ock et al. Oncotarget
- Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy
- (2017) Kellie B. Haworth et al. Oncotarget
- PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
- (2017) Shengwei Liu et al. Oncotarget
- Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway
- (2017) Ming Jing Shen et al. Oncotarget
- NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
- (2017) Ya Zhou et al. Oncotarget
- Low-dose levels of bisphenol A inhibit telomerase via ER/GPR30-ERK signalling, impair DNA integrity and reduce cell proliferation in primary PBMC
- (2017) Corinna Herz et al. Scientific Reports
- Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
- (2017) Oakley C. Olson et al. Cell Reports
- DAF-18/PTEN signals through AAK-1/AMPK to inhibit MPK-1/MAPK in feedback control of germline stem cell proliferation
- (2017) Patrick Narbonne et al. PLoS Genetics
- miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
- (2017) S-L Tung et al. Oncogenesis
- Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
- (2017) Li Yang et al. Scientific Reports
- Hypoxia regulates ABCG2activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells
- (2016) Xiaodan He et al. CANCER BIOLOGY & THERAPY
- MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
- (2016) Youguang Pu et al. Cancer Cell International
- Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis
- (2016) Yun-Xin Lu et al. CANCER LETTERS
- Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation
- (2016) RYOTA KURIMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
- (2016) Nan Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- RAS isoforms and mutations in cancer at a glance
- (2016) G. Aaron Hobbs et al. JOURNAL OF CELL SCIENCE
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
- (2016) H Zhang et al. ONCOGENE
- Selective GPR55 antagonism reduces chemoresistance in cancer cells
- (2016) Nagendra S. Singh et al. PHARMACOLOGICAL RESEARCH
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)
- (2016) Andrew M. Kidger et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
- (2016) Lin Lv et al. TUMOR BIOLOGY
- The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
- (2016) Hui-Mian Xu et al. OncoTargets and Therapy
- ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells
- (2016) Jianye Cai et al. Cell Death & Disease
- Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors
- (2016) Joanna Kopecka et al. Oncotarget
- Positive feedback regulation between IL10 and EGFR promotes lung cancer formation
- (2016) Tsung-I Hsu et al. Oncotarget
- Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
- (2016) Jiang Chen et al. Oncotarget
- Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis
- (2016) Madison Black et al. Oncotarget
- DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
- (2016) Francesca Megiorni et al. Oncotarget
- PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness
- (2016) Ming-Jenn Chen et al. Scientific Reports
- Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
- (2016) S. Zdanov et al. Cancer Immunology Research
- Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement
- (2016) Pauline Gravelle et al. OncoImmunology
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
- (2016) Hidetoshi Sumimoto et al. PLoS One
- p-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway
- (2016) Ming Ma et al. Scientific Reports
- Primary pineal malignant melanoma with B-Raf V600E mutation: a case report and brief review of the literature
- (2015) Kathleen Jetschke et al. ACTA NEUROCHIRURGICA
- DJ-1 as a human oncogene and potential therapeutic target
- (2015) Ji Cao et al. BIOCHEMICAL PHARMACOLOGY
- Ras activation revisited: role of GEF and GAP systems
- (2015) Anne Hennig et al. BIOLOGICAL CHEMISTRY
- Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
- (2015) Seyedmehdi Shojaee et al. CANCER CELL
- Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions
- (2015) Hye-Jin Hong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFN That Induce PD-L1 Expression in Head and Neck Cancer
- (2015) F. Concha-Benavente et al. CANCER RESEARCH
- Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) K. Ota et al. CLINICAL CANCER RESEARCH
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2015) S. Loi et al. CLINICAL CANCER RESEARCH
- Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection
- (2015) Zhong Fang et al. JOURNAL OF IMMUNOLOGY
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines
- (2015) YUAN-YUAN ZHAO et al. Molecular Medicine Reports
- Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
- (2015) Xiaoguang Tong et al. Molecular Oncology
- Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5’-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs
- (2015) Valérie Vinette et al. PLoS One
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Endoplasmic Reticulum Stress-Activated Cell Reprogramming in Oncogenesis
- (2015) E. Chevet et al. Cancer Discovery
- Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells
- (2015) Joanna Kopecka et al. Oncotarget
- Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
- (2015) Micol Rigoni et al. Oncotarget
- A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
- (2015) Maria Gato-Cañas et al. Oncotarget
- TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
- (2015) Victor Ho et al. Oncotarget
- LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma
- (2015) Gabriella Cunha Vieira et al. Oncotarget
- Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
- (2015) Xinqun Chai et al. Scientific Reports
- Paracrine communication maximizes cellular response fidelity in wound signaling
- (2015) L Naomi Handly et al. eLife
- Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells
- (2015) Zhao Liu et al. PLoS One
- Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
- (2015) Iris Chiara Salaroglio et al. Oncotarget
- Exogenous IGFBP-2 promotes proliferation, invasion and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
- (2014) B. J. Wilson et al. CANCER RESEARCH
- Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer
- (2014) Zhiqing Fang et al. FOOD AND CHEMICAL TOXICOLOGY
- Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer
- (2014) Weifeng Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Environmental Stress Affects the Activity of Metabolic and Growth Factor Signaling Networks and Induces Autophagy Markers in MCF7 Breast Cancer Cells
- (2014) Pedro Casado et al. MOLECULAR & CELLULAR PROTEOMICS
- CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
- (2014) Hsiao-Chi Tsai et al. PLoS One
- Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression
- (2014) Linda K. Rushworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway
- (2013) Hee-Jin Ahn et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis
- (2013) Houpu Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
- (2013) Alicia S Chung et al. NATURE MEDICINE
- Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
- (2013) C. Riganti et al. NEURO-ONCOLOGY
- PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling
- (2013) B Zhu et al. ONCOGENE
- Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
- (2013) Chiara Riganti et al. PLoS One
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
- (2012) Dalila Naci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High DGK- and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention
- (2012) P. U. Prinz et al. JOURNAL OF IMMUNOLOGY
- Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner
- (2012) Mohammed-Amine El Azreq et al. MOLECULAR BIOLOGY OF THE CELL
- The Activation of MEK/ERK Signaling Pathway by Bone Morphogenetic Protein 4 to Increase Hepatocellular Carcinoma Cell Proliferation and Migration
- (2012) C.-Y. Chiu et al. MOLECULAR CANCER RESEARCH
- The unfolded protein response: controlling cell fate decisions under ER stress and beyond
- (2012) Claudio Hetz NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The Outgrowth of Micrometastases Is Enabled by the Formation of Filopodium-like Protrusions
- (2012) Tsukasa Shibue et al. Cancer Discovery
- IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin upregulation
- (2011) Hernan Roca et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
- (2011) P. Hemon et al. JOURNAL OF IMMUNOLOGY
- Activation of mitogen activated protein kinase-Erk kinase (MEK) increases T cell immunoglobulin mucin domain-3 (TIM-3) transcription in human T lymphocytes and a human mast cell line
- (2011) Soo-Jin Yoon et al. MOLECULAR IMMUNOLOGY
- Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers
- (2010) S. Pillozzi et al. BLOOD
- Mechanism of genotoxicity induced by targeted cytoplasmic irradiation
- (2010) M Hong et al. BRITISH JOURNAL OF CANCER
- Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
- (2010) Joanna Kopecka et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo
- (2010) J P Robinson et al. ONCOGENE
- Down-Regulation of DUSP6 Expression in Lung Cancer
- (2009) Koji Okudela et al. AMERICAN JOURNAL OF PATHOLOGY
- 1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
- (2009) D. Lesniak et al. CANCER RESEARCH
- Integrin 1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
- (2009) T. Shibue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started